Study identifies a C3 gene variant that impairs immune regulation and increases CLAD risk after lung transplantation. Did You ...
Spanish Economy Minister says Europeans must stay united and keep focused on integration after the Trump administration said ...
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor ...
The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization ...
A donor unknowingly carrying a dangerous TP53 cancer mutation fathered nearly 200 children across Europe, leading to devastating diagnoses, and renewed scrutiny of sperm-donor limits and international ...
CAAR ruled that multi-functional PCR instruments cannot be treated as spectrometers where optical detection is only one part ...
Morning Overview on MSN
Morning orange juice triggers changes in thousands of immune genes
For years, orange juice has been sold as a simple source of vitamin C, but new human data suggest that a morning glass may be ...
A research team led by Dr. Àlex Bayés, Head of the Molecular Physiology of the Synapse Group at the Institut de Recerca Sant ...
Eli Drinkwitz ‘has proven his ability to navigate all this in such an intelligent, strategic way that a lot of coaches ...
Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering. The global GMP cytokine market is expected to grow with a CAGR of 8.4% from 2025 to 2031. The ...
In atopic dermatitis, the first interleukin-22 inhibitor to reach late clinical trials is showing uncommonly broad suppression of biomarkers associated with disease activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results